文献速递神经外科与老年麻醉心胸血管麻醉

围术期右美托咪定对心脏与非心脏手术患者术后谵妄发生率的影响:随机双盲安慰剂对照试验

The effect of peri-operative dexmedetomidine on the incidence of postoperative delirium in cardiac and non-cardiac surgical patients: a randomised, double-blind placebo-controlled trial.
PubMed 文献 · Anaesthesia · 2021-05-07

该随机双盲安慰剂对照试验纳入63例≥60岁接受大型开腹手术或体外循环冠状动脉旁路移植术的患者,发现围术期右美托咪定组术后5天内谵妄发生率显著低于安慰剂组(43.8% vs. 17.9%,p=0.038),且右美托咪定组无死亡而安慰剂组有5例(15.6%)死亡(p=0.029)。

要点

  • ≥60岁大型心脏或非心脏手术患者围术期使用右美托咪定可降低术后5天内谵妄发生率。
  • 右美托咪定组谵妄严重程度与安慰剂组无显著差异。
  • 右美托咪定组无死亡,安慰剂组死亡5例(15.6%),差异有统计学意义。

核心结论

  • 对于≥60岁接受大型心脏或非心脏手术的患者,围术期给予右美托咪定与术后谵妄发生率降低相关。

研究设计与样本

  • 随机双盲安慰剂对照试验,纳入63例≥60岁接受大型开腹手术或体外循环冠状动脉旁路移植术的患者。

主要发现

  • 右美托咪定组术后5天内谵妄发生率为17.9%,安慰剂组为43.8%,p=0.038。
  • 两组谵妄严重程度(重症监护谵妄筛查清单最大评分均值)分别为1.54 vs. 1.68,p=0.767。
  • 右美托咪定组无患者死亡,安慰剂组有5例(15.6%)死亡,p=0.029。

关键数值与推荐

  • 谵妄评估使用混淆评估法,每日两次直至术后第5天、出院时或术后第14天。
  • 谵妄严重程度使用重症监护谵妄筛查清单评估。

临床怎么用

  • 对于≥60岁接受大型开腹手术或体外循环冠状动脉旁路移植术的患者,可考虑围术期使用右美托咪定以降低术后谵妄发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Delirium occurs commonly following major non-cardiac and cardiac surgery and is associated with: postoperative mortality; postoperative neurocognitive dysfunction; increased length of hospital stay; and major postoperative complications and morbidity. The aim of this study was to investigate the effect of peri-operative administration of dexmedetomidine on the incidence of postoperative delirium in non-cardiac and cardiac surgical patients. In this randomised, double-blind placebo-controlled trial we included 63 patients aged ≥ 60 years undergoing major open abdominal surgery or coronary artery bypass graft surgery with cardiopulmonary bypass. The primary outcome was the incidence of postoperative delirium, as screened for with the Confusion Assessment Method. Delirium assessment was performed twice daily until postoperative day 5, at the time of discharge from hospital or until postoperative day 14. We found that dexmedetomidine was associated with a reduced incidence of postoperative delirium within the first 5 postoperative days, 43.8% vs. 17.9%, p = 0.038. Severity of delirium, screened with the Intensive Care Delirium Screening Checklist, was comparable in both groups, with a mean maximum score of 1.54 vs. 1.68, p = 0.767. No patients in the dexmedetomidine group died while five (15.6%) patients in the placebo group died, p = 0.029. For patients aged ≥ 60 years undergoing major cardiac or non-cardiac surgery, we conclude that the peri-operative administration of dexmedetomidine is associated with a lower incidence of postoperative delirium.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. van Norden J, Spies CD, Borchers F, et al. The effect of peri-operative dexmedetomidine on the incidence of postoperative delirium in cardiac and non-cardiac surgical patients: a randomised, double-blind placebo-controlled trial. Anaesthesia. 2021. PMID: 33960404. doi:10.1111/anae.15469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。